Resource-Stratified Decision Trees for Aneurysmal Subarachnoid Hemorrhage
MENA-SINO aSAH Decision Algorithms
Resource-Stratified Decision Trees for Aneurysmal Subarachnoid Hemorrhage
Initial Assessment
Decision Point
Action Required
Critical/Time-Sensitive
Tier 1: Basic Emergency Care Algorithm
Suspected aSAH Patient
Sudden severe headache, altered consciousness, or neurological deficits
Sudden severe headache, altered consciousness, or neurological deficits
Initial Assessment & Stabilization
Immediate Actions (First 15 minutes):
- ABC assessment and stabilization
- IV access and basic monitoring
- Clinical grading (Hunt & Hess or WFNS)
- Blood pressure management (SBP 140-180 mmHg)
- Glucose and electrolyte check
CT Scanner Available?
YES: Non-contrast CT
Within 6 hours of symptom onset
Within 6 hours of symptom onset
â° Time Critical: CT within 1 hour if possible
CT Shows SAH?
aSAH Confirmed
Proceed to transfer preparation
Proceed to transfer preparation
High Clinical Suspicion?
Consider LP if >6 hours from onset
Consider LP if >6 hours from onset
NO: Lumbar Puncture
If clinically stable and no contraindications
If clinically stable and no contraindications
LP Procedure:
- Check for contraindications
- Visual inspection for xanthochromia
- Send for cell count and protein
- Document opening pressure
Xanthochromia Present?
aSAH Confirmed – Immediate Management
Essential Medications (if available):
- Nimodipine 60mg PO q4h (preferred) or 1-2mg/h IV
- Seizure prophylaxis if high-risk features
- Pain management (avoid morphine if possible)
- DVT prophylaxis (mechanical if bleeding risk)
Transfer Safe & Feasible?
Consider distance, transport, weather, security
Consider distance, transport, weather, security
EMERGENCY TRANSFER
Pre-transfer Contact:
📞 Call receiving facility
📋 Provide SBAR handoff
🚑 Arrange transport with monitor
📞 Call receiving facility
📋 Provide SBAR handoff
🚑 Arrange transport with monitor
Transfer Checklist:
- Stable airway and breathing
- IV access secured
- Medications continued
- All imaging copied
- Family notification
Stabilize Locally
Prepare for delayed transfer
Prepare for delayed transfer
Consider tranexamic acid 1g IV q8h until transfer possible (max 72 hours)
Monitoring & Reassessment:
- Neurological checks q1-2h
- Blood pressure monitoring
- Reassess transfer feasibility q6h
- Family communication
- Document all interventions
Tier 2: Intermediate Capability Algorithm
aSAH Patient Received
Direct admission or transfer from Tier 1
Direct admission or transfer from Tier 1
Comprehensive Assessment
Advanced Evaluation:
- Complete neurological examination
- CTA if available (preferred within 6h)
- Basic laboratory panel
- ECG and chest X-ray
- Reassess clinical grade
Aneurysm Identified on CTA?
Treatment Capability Assessment
Local Capability Check:
- Neurosurgeon available?
- Endovascular capability?
- Anesthesia and OR ready?
- ICU bed available?
- Blood bank prepared?
Can Treat Locally?
Consider aneurysm complexity
Consider aneurysm complexity
Proceed with Treatment
Target: Within 24 hours
Target: Within 24 hours
â° Rebleeding risk highest in first 24 hours
Treatment Selection:
- Anterior circulation: Consider both options
- Posterior circulation: Prefer coiling
- Young patients: Consider clipping durability
- Elderly patients: Consider coiling safety
Stabilize & Transfer to Tier 3
Urgent Consultation:
📞 Direct physician-to-physician contact
📧 Send imaging via secure transfer
🥠Arrange expedited transfer
📞 Direct physician-to-physician contact
📧 Send imaging via secure transfer
🥠Arrange expedited transfer
No Aneurysm Visible
Consider non-aneurysmal SAH or occult aneurysm
Consider non-aneurysmal SAH or occult aneurysm
Consider transfer to Tier 3 for DSA if high clinical suspicion and negative CTA
Post-Treatment Management
ICU Monitoring (Days 1-14):
- Neurological assessments q1-2h
- Blood pressure management
- Vasospasm surveillance (TCD if available)
- Fluid balance and electrolytes
- Early mobilization when safe
Complications Developing?
Vasospasm, hydrocephalus, medical issues
Vasospasm, hydrocephalus, medical issues
Manage Complications
Available Interventions:
- Induced hypertension for vasospasm
- EVD for hydrocephalus
- Medical optimization
- Consider transfer if refractory
Continue Standard Care
Plan for rehabilitation and discharge
Plan for rehabilitation and discharge
Tier 3: Comprehensive Centers Algorithm
aSAH Patient Received
All patients + complex transfers from Tier 1/2
All patients + complex transfers from Tier 1/2
Multidisciplinary Assessment
Team Evaluation:
- Neurosurgery evaluation
- Neurointerventional assessment
- Neurocritical care consultation
- Anesthesia planning
- Advanced imaging (DSA if needed)
Treatment Planning Conference
Optimal modality selection
Optimal modality selection
Decision Factors:
- Aneurysm location and morphology
- Patient age and comorbidities
- Clinical grade and timing
- Operator expertise
- Research protocol eligibility
Optimal Treatment Selection
No resource constraints
No resource constraints
Endovascular Treatment
Advanced Options:
- Simple coiling
- Balloon-assisted coiling
- Stent-assisted coiling
- Flow diversion (select cases)
- WEB devices
Surgical Treatment
Advanced Techniques:
- Microsurgical clipping
- Bypass procedures
- Clot evacuation
- CSF diversion
- Combined approaches
Advanced Monitoring & Management
Comprehensive Care:
- Multimodality neuromonitoring
- Advanced vasospasm management
- Endovascular rescue procedures
- Specialized nursing care
- Early rehabilitation
Refractory Complications?
Severe vasospasm, medical complications
Severe vasospasm, medical complications
Advanced Interventions
Rescue Options:
- Intra-arterial vasodilators
- Balloon angioplasty
- Advanced ICU management
- Experimental protocols
Standard Recovery
Comprehensive rehabilitation
Comprehensive rehabilitation
Long-term Follow-up Planning
Comprehensive Follow-up:
- Imaging surveillance protocol
- Neuropsychological assessment
- Quality of life evaluation
- Return to work planning
- Family screening if indicated
Regional Support Role:
📞 Consultation for Tier 1/2 centers
📚 Training and education
📊 Quality improvement initiatives
🔬 Research leadership
📞 Consultation for Tier 1/2 centers
📚 Training and education
📊 Quality improvement initiatives
🔬 Research leadership
MENA-SINO aSAH Guidelines © 2024 | For internal medical use only
Always consider local resources, patient factors, and clinical judgment
